{
    "accountDetails": {
        "accountHasCodexViolations": false,
        "activeDateRanges": [
            {
                "fromDate": "2024-05-08T17:16:46.000+02:00"
            }
        ],
        "firstPublicationDate": "2024-05-08T17:16:46.000+02:00",
        "lastUpdateDate": "2024-06-10T15:15:25.000+02:00",
        "registerEntryVersions": [
            {
                "legislation": "GL2024",
                "registerEntryId": 36321,
                "validFromDate": "2024-06-10T15:15:25.000+02:00",
                "version": 3,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2024",
                "registerEntryId": 35237,
                "validFromDate": "2024-06-03T11:40:01.000+02:00",
                "validUntilDate": "2024-06-10T15:15:25.000+02:00",
                "version": 2,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2024",
                "registerEntryId": 30810,
                "validFromDate": "2024-05-08T17:16:46.000+02:00",
                "validUntilDate": "2024-06-03T11:40:01.000+02:00",
                "version": 1,
                "versionActiveLobbyist": true
            }
        ]
    },
    "activeLobbyist": true,
    "activitiesAndInterests": {
        "activity": {
            "code": "ACT_ORGANIZATION_V2",
            "de": "Sonstiges Unternehmen",
            "en": "Other company"
        },
        "activityDescription": "Incyte Deutschland ist ein junges, hochinnovatives Pharmaunternehmen mit Hauptsitz in M\u00fcnchen. Auch hierzulande bieten wir Medikamente gegen dringend behandlungsbed\u00fcrftige Krebsarten und Autoimmunerkrankungen, f\u00fcr die es bisher keine oder nur begrenzte Behandlungsm\u00f6glichkeiten gibt. Unser Antrieb hei\u00dft Solve On. Das bedeutet: Wir suchen st\u00e4ndig nach neuen, noch besseren Therapien zum Wohl unserer Patienten. Sie stehen f\u00fcr uns an erster Stelle. Unser Ziel ist es, ihr Leben zu verbessern und m\u00f6glichst zu verl\u00e4ngern \u2013 unabh\u00e4ngig von der Gr\u00f6\u00dfe der Patientengruppe.",
        "fieldsOfInterest": [
            {
                "code": "FOI_HEALTH_CARE",
                "de": "Pflege",
                "en": "Health care"
            },
            {
                "code": "FOI_HEALTH_PROMOTION",
                "de": "Gesundheitsf\u00f6rderung",
                "en": "Health promotion"
            },
            {
                "code": "FOI_HEALTH_OTHER",
                "de": "Sonstiges im Bereich \"Gesundheit\"",
                "en": "Other in the field of \"Health\""
            },
            {
                "code": "FOI_HEALTH_SUPPLY",
                "de": "Gesundheitsversorgung",
                "en": "Health supply"
            },
            {
                "code": "FOI_HEALTH",
                "de": "Gesundheit",
                "en": "Health"
            },
            {
                "code": "FOI_HEALTH_MEDICINE",
                "de": "Arzneimittel",
                "en": "Medicine"
            }
        ],
        "typesOfExercisingLobbyWork": [
            {
                "code": "SELF_OPERATED_OWN_INTEREST",
                "de": "Die Interessenvertretung wird in eigenem Interesse selbst wahrgenommen",
                "en": "Interest representation is self-performed in its own interest"
            },
            {
                "code": "CONTRACTS_OPERATED_BY_THIRD_PARTY",
                "de": "Die Interessenvertretung wird in eigenem Interesse durch die Beauftragung Dritter wahrgenommen",
                "en": "Contracts are awarded to third parties to represent own interests of the company"
            }
        ]
    },
    "annualReports": {
        "annualReportPdfUrl": "https://www.lobbyregister.bundestag.de/media/0a/57/286739/INCY_2023_Proxy.pdf",
        "annualReportPreviousLastFiscalYearExists": true,
        "relatedFiscalYearEnd": "2022-12-31",
        "relatedFiscalYearStart": "2022-01-01"
    },
    "codeOfConduct": {
        "ownCodeOfConduct": false
    },
    "contracts": {
        "contracts": [],
        "contractsPresent": false
    },
    "donators": {
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalDonationsEuro": {
            "from": 0,
            "to": 0
        }
    },
    "employeesInvolvedInLobbying": {
        "employeeFTE": 0.5,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "financialExpenses": {
        "financialExpensesEuro": {
            "from": 20001,
            "to": 30000
        },
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "legislation": "GL2024",
    "lobbyistIdentity": {
        "address": {
            "city": "M\u00fcnchen",
            "country": {
                "code": "DE",
                "de": "Deutschland",
                "en": "Germany"
            },
            "street": "Perchtinger Stra\u00dfe ",
            "streetNumber": "8",
            "type": "NATIONAL",
            "zipCode": "81379"
        },
        "capitalCityRepresentationPresent": false,
        "contactDetails": {
            "emails": [
                {
                    "email": "MGernet@incyte.com"
                }
            ],
            "phoneNumber": "+4989203010850",
            "websites": [
                {
                    "website": "www.incytebiosciences.de"
                }
            ]
        },
        "entrustedPersons": [
            {
                "firstName": "Peter",
                "lastName": "Mutzenbecher",
                "recentGovernmentFunctionPresent": false
            },
            {
                "academicDegreeBefore": "Dr.",
                "firstName": "Regina",
                "lastName": "Widner-Andr\u00e4",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Martina",
                "lastName": "Gernet",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Benedikt ",
                "lastName": "B\u00f6hme",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "entrustedPersonsPresent": true,
        "identity": "ORGANIZATION",
        "legalForm": {
            "code": "LF_GMBH",
            "de": "Gesellschaft mit beschr\u00e4nkter Haftung (GmbH)",
            "en": "Limited liability company (GmbH)"
        },
        "legalFormType": {
            "code": "JURISTIC_PERSON",
            "de": "Juristische Person",
            "en": "Legal person"
        },
        "legalRepresentatives": [
            {
                "entrustedPerson": true,
                "firstName": "Peter",
                "function": "Gesch\u00e4ftsf\u00fchrer",
                "lastName": "Mutzenbecher",
                "recentGovernmentFunctionPresent": false
            },
            {
                "entrustedPerson": false,
                "firstName": "Jonathan",
                "function": "Executive Vice President and General Manager, Europe",
                "lastName": "Dickinson",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "membersPresent": false,
        "memberships": [
            {
                "membership": "Bundesverband der Pharmazeutischen Industrie e.V."
            },
            {
                "membership": "Berufsverband der Deutschen Dermatologen e.V. "
            },
            {
                "membership": "Deutsche Dermatologische Gesellschaft e.V."
            },
            {
                "membership": "Arzneimittel und Kooperation im Gesundheitswesen e.V."
            }
        ],
        "membershipsPresent": true,
        "name": "Incyte Biosciences Germany "
    },
    "mainFundingSources": {
        "mainFundingSources": [
            {
                "code": "MFS_ECONOMIC_ACTIVITY",
                "de": "Wirtschaftliche T\u00e4tigkeit",
                "en": "Economic activity"
            }
        ],
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "membershipFees": {
        "individualContributors": [],
        "individualContributorsPresent": false,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalMembershipFees": {
            "from": 0,
            "to": 0
        }
    },
    "publicAllowances": {
        "publicAllowancesPresent": false,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "registerEntryDetails": {
        "detailsPageUrl": "https://www.lobbyregister.bundestag.de/suche/R006678/36321",
        "pdfUrl": "https://www.lobbyregister.bundestag.de/media/72/2a/286740/Lobbyregister-Detailansicht-R006678-2024-06-10_15-15-25.pdf",
        "validFromDate": "2024-06-10T15:15:25.000+02:00",
        "version": 3
    },
    "registerEntryId": 36321,
    "registerNumber": "R006678",
    "regulatoryProjects": {
        "regulatoryProjects": [
            {
                "affectedLaws": [],
                "affectedLawsPresent": false,
                "description": "Wir setzen uns f\u00fcr eine konstruktive, patientengerichtete Debatte bzgl. des Orphan-Privilegs im Rahmen einer m\u00f6glichen, zuk\u00fcnftigen AMNOG-Reform ein.",
                "draftBillPresent": false,
                "fieldsOfInterest": [
                    {
                        "code": "FOI_HEALTH",
                        "de": "Gesundheit",
                        "en": "Health"
                    },
                    {
                        "code": "FOI_HEALTH_MEDICINE",
                        "de": "Arzneimittel",
                        "en": "Medicine"
                    },
                    {
                        "code": "FOI_HEALTH_SUPPLY",
                        "de": "Gesundheitsversorgung",
                        "en": "Health supply"
                    }
                ],
                "printedMatters": [],
                "printedMattersPresent": false,
                "regulatoryProjectNumber": "RV0001709",
                "statements": [],
                "title": "M\u00f6gliche AMNOG-Reform "
            }
        ],
        "regulatoryProjectsPresent": true
    },
    "statements": {
        "statements": [],
        "statementsPresent": false
    }
}